Drug Profile
U 143677
Alternative Names: PNU 143677Latest Information Update: 23 Feb 2000
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 23 Feb 2000 No-Development-Reported for Undefined in USA (Unknown route)
- 16 May 1997 Preclinical development for Undefined in USA (Unknown route)